PubRank
Search
About
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples (Partners PrEP)
Clinical Trial ID NCT00557245
PubWeight™ 62.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00557245
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
N Engl J Med
2012
27.84
2
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.
Lancet
2011
6.91
3
What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
J Acquir Immune Defic Syndr
2012
3.44
4
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
PLoS One
2011
3.27
5
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
J Acquir Immune Defic Syndr
2014
2.43
6
Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
JAMA Intern Med
2015
2.35
7
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis.
Lancet Infect Dis
2013
2.18
8
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.
Lancet Infect Dis
2014
2.05
9
Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
JAMA
2014
1.73
10
Persisting with prevention: the importance of adherence for HIV prevention.
Emerg Themes Epidemiol
2008
1.71
11
Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
Ann Intern Med
2014
1.24
12
My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya.
AIDS Care
2014
1.12
13
Achieving pregnancy safely: perspectives on timed vaginal insemination among HIV-serodiscordant couples and health-care providers in Kisumu, Kenya.
AIDS Care
2014
1.04
14
Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women.
AIDS Behav
2013
0.98
15
Controlling the HIV/AIDS epidemic: current status and global challenges.
Front Immunol
2012
0.92
16
Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.
J Infect Dis
2014
0.83
17
A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.
Expert Opin Investig Drugs
2012
0.82
18
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
J Infect Dis
2016
0.81
19
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
PLoS One
2011
0.78
20
Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention.
Pharm Pract (Granada)
2009
0.78
21
Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men.
AIDS
2014
0.76
22
HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
J Virol
2016
0.75
23
Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection.
J Acquir Immune Defic Syndr
2016
0.75
Next 100